286 related articles for article (PubMed ID: 32372707)
1. TRA2A-induced upregulation of LINC00662 regulates blood-brain barrier permeability by affecting ELK4 mRNA stability in Alzheimer's microenvironment.
Liu Q; Zhu L; Liu X; Zheng J; Liu Y; Ruan X; Cao S; Cai H; Li Z; Xue Y
RNA Biol; 2020 Sep; 17(9):1293-1308. PubMed ID: 32372707
[TBL] [Abstract][Full Text] [Related]
2. The role of LINC00094/miR-224-5p (miR-497-5p)/Endophilin-1 axis in Memantine mediated protective effects on blood-brain barrier in AD microenvironment.
Zhu L; Lin M; Ma J; Liu W; Gao L; Wei S; Xue Y; Shang X
J Cell Mol Med; 2019 May; 23(5):3280-3292. PubMed ID: 30801976
[TBL] [Abstract][Full Text] [Related]
3. PART1 destabilized by NOVA2 regulates blood-brain barrier permeability in endothelial cells via STAU1-mediated mRNA degradation.
Ning H; Zhang T; Zhou X; Liu L; Shang C; Qi R; Ma T
Gene; 2022 Mar; 815():146164. PubMed ID: 34990795
[TBL] [Abstract][Full Text] [Related]
4. RBM3 enhances the stability of MEF2C mRNA and modulates blood-brain barrier permeability in AD microenvironment.
Ding Y; Lin M; Wang J; Shang X
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119738. PubMed ID: 38670534
[TBL] [Abstract][Full Text] [Related]
5. Aβ
Chan Y; Chen W; Wan W; Chen Y; Li Y; Zhang C
Exp Cell Res; 2018 Aug; 369(2):266-274. PubMed ID: 29856989
[TBL] [Abstract][Full Text] [Related]
6. TARBP2-stablized SNHG7 regulates blood-brain barrier permeability by acting as a competing endogenous RNA to miR-17-5p/NFATC3 in Aβ-microenvironment.
Ning H; Zhang L; Zhu B; Zhou X; Zhang T; Ma T
Cell Death Dis; 2022 May; 13(5):457. PubMed ID: 35562351
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1.
Liu W; Cai H; Lin M; Zhu L; Gao L; Zhong R; Bi S; Xue Y; Shang X
Exp Cell Res; 2016 May; 343(2):248-257. PubMed ID: 27038654
[TBL] [Abstract][Full Text] [Related]
8. Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer's disease.
Jana A; Wang X; Leasure JW; Magana L; Wang L; Kim YM; Dodiya H; Toth PT; Sisodia SS; Rehman J
Sci Rep; 2022 Oct; 12(1):16488. PubMed ID: 36182964
[TBL] [Abstract][Full Text] [Related]
9. ZNF787 and HDAC1 Mediate Blood-Brain Barrier Permeability in an In Vitro Model of Alzheimer's Disease Microenvironment.
Zhang L; Zhu B; Zhou X; Ning H; Zhang F; Yan B; Chen J; Ma T
Neurotox Res; 2024 Feb; 42(1):12. PubMed ID: 38329647
[TBL] [Abstract][Full Text] [Related]
10. miR-424-5p maybe regulate blood-brain barrier permeability in a model in vitro with Abeta incubated endothelial cells.
Lin M; Zhu L; Wang J; Xue Y; Shang X
Biochem Biophys Res Commun; 2019 Sep; 517(3):525-531. PubMed ID: 31375213
[TBL] [Abstract][Full Text] [Related]
11. Pseudogene ACTBP2 increases blood-brain barrier permeability by promoting KHDRBS2 transcription through recruitment of KMT2D/WDR5 in Aβ
Liu Q; Liu X; Zhao D; Ruan X; Su R; Shang X; Wang D; Yang C; Xue Y
Cell Death Discov; 2021 Jun; 7(1):142. PubMed ID: 34127651
[TBL] [Abstract][Full Text] [Related]
12. IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay.
Liu X; Wu P; Su R; Xue Y; Yang C; Wang D; Ruan X; Zheng J; Yang Y; Li Z; Liu Y
RNA Biol; 2020 Dec; 17(12):1777-1788. PubMed ID: 32713259
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
14. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
Yang H; Wang W; Jia L; Qin W; Hou T; Wu Q; Li H; Tian Y; Jia J
J Alzheimers Dis; 2020; 74(1):261-275. PubMed ID: 32007956
[TBL] [Abstract][Full Text] [Related]
16. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
17. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model.
Versele R; Sevin E; Gosselet F; Fenart L; Candela P
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142143
[TBL] [Abstract][Full Text] [Related]
18. Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro.
Cuevas E; Rosas-Hernandez H; Burks SM; Ramirez-Lee MA; Guzman A; Imam SZ; Ali SF; Sarkar S
Metab Brain Dis; 2019 Oct; 34(5):1365-1374. PubMed ID: 31267346
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
Festoff BW; Sajja RK; van Dreden P; Cucullo L
J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
[TBL] [Abstract][Full Text] [Related]
20. Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins.
Wan W; Cao L; Liu L; Zhang C; Kalionis B; Tai X; Li Y; Xia S
J Neurochem; 2015 Jul; 134(2):382-93. PubMed ID: 25866188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
